OPKO Health, Inc. Payments to Acquire Productive Assets
OPKO Health, Inc. (OPK) reported Payments to Acquire Productive Assets of $4.84 million for the 6-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-08-28
- OPKO Health, Inc. payments to acquire productive assets for the quarter ending 2026-06-30 was $3.00M, a 8.50% decline year-over-year.
- OPKO Health, Inc. payments to acquire productive assets for the quarter ending 2026-03-31 was $1.83M, a 42.61% decline year-over-year.
- OPKO Health, Inc. payments to acquire productive assets for the quarter ending 2025-12-31 was $2.67M, a 50.75% decline year-over-year.
- OPKO Health, Inc. payments to acquire productive assets for the quarter ending 2025-09-30 was $3.13M, a 60.50% decline year-over-year.
- OPKO Health, Inc. payments to acquire productive assets for fiscal 2025 was $12.28M, a 50.91% decline from fiscal 2024.
- OPKO Health, Inc. payments to acquire productive assets for fiscal 2024 was $25.01M, a 53.67% increase from fiscal 2023.
- OPKO Health, Inc. payments to acquire productive assets for fiscal 2023 was $16.27M, a 33.78% decline from fiscal 2022.
- OPKO Health, Inc. payments to acquire productive assets for fiscal 2022 was $24.58M, a 23.57% decline from fiscal 2021.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.00M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $4.84M 10-Q/A · filed 2026-08-28 | $7.50M derived: sum of 3 quarters · filed 2026-08-28 | $10.64M derived: sum of 4 quarters · filed 2026-08-28 |
| 2026-03-31 | $1.83M 10-Q/A · filed 2026-08-28 | $4.50M derived: sum of 2 quarters · filed 2026-08-28 | $7.63M derived: sum of 3 quarters · filed 2026-08-28 | $10.92M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.80M derived: sum of 2 quarters · filed 2026-02-26 | $9.08M derived: sum of 3 quarters · filed 2026-08-28 | $12.28M 10-K · filed 2026-02-26 |
| 2025-09-30 | $3.13M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-10-29 | $6.42M derived: sum of 2 quarters · filed 2026-08-28 | $9.61M 10-Q · filed 2025-10-29 | $15.03M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-06-30 | $3.28M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $6.48M 10-Q/A · filed 2026-08-28 | $11.89M derived: sum of 3 quarters · filed 2026-08-28 | $19.83M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-03-31 | $3.19M 10-Q/A · filed 2026-08-28 | $8.61M derived: sum of 2 quarters · filed 2026-08-28 | $16.54M derived: sum of 3 quarters · filed 2026-08-28 | $23.76M derived: sum of 4 quarters · filed 2026-08-28 |
| 2024-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $13.35M derived: sum of 2 quarters · filed 2026-02-26 | $20.57M derived: sum of 3 quarters · filed 2026-02-26 | $25.01M 10-K · filed 2026-02-26 |
| 2024-09-30 | $7.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $15.15M derived: sum of 2 quarters · filed 2025-10-29 | $19.60M 10-Q · filed 2025-10-29 | $22.62M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $7.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $11.66M 10-Q · filed 2025-07-31 | $14.68M derived: sum of 3 quarters · filed 2026-02-26 | $18.89M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $4.44M 10-Q · filed 2025-05-01 | $7.46M derived: sum of 2 quarters · filed 2026-02-26 | $11.67M derived: sum of 3 quarters · filed 2026-02-26 | $17.68M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.22M derived: sum of 2 quarters · filed 2026-02-26 | $13.24M derived: sum of 3 quarters · filed 2026-02-26 | $16.27M 10-K · filed 2026-02-26 |
| 2023-09-30 | $4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $10.22M derived: sum of 2 quarters · filed 2024-11-07 | $13.25M 10-Q · filed 2024-11-07 | $19.59M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $6.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $9.05M 10-Q · filed 2024-08-07 | $15.39M derived: sum of 3 quarters · filed 2025-03-03 | $23.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $3.04M 10-Q · filed 2024-05-07 | $9.37M derived: sum of 2 quarters · filed 2025-03-03 | $16.98M derived: sum of 3 quarters · filed 2025-03-03 | $22.36M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $13.95M derived: sum of 2 quarters · filed 2025-03-03 | $19.33M derived: sum of 3 quarters · filed 2025-03-03 | $24.58M 10-K · filed 2025-03-03 |
| 2022-09-30 | $7.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $12.99M derived: sum of 2 quarters · filed 2023-11-06 | $18.24M 10-Q · filed 2023-11-06 | $24.97M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-06-30 | $5.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $10.63M 10-Q · filed 2023-08-03 | $17.36M derived: sum of 3 quarters · filed 2024-03-01 | $24.59M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-03-31 | $5.25M 10-Q · filed 2023-05-03 | $11.98M derived: sum of 2 quarters · filed 2024-03-01 | $19.21M derived: sum of 3 quarters · filed 2024-03-01 | $28.16M derived: sum of 4 quarters · filed 2024-03-01 |
| 2021-12-31 | $6.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $13.96M derived: sum of 2 quarters · filed 2024-03-01 | $22.91M derived: sum of 3 quarters · filed 2024-03-01 | $32.16M 10-K · filed 2024-03-01 |
| 2021-09-30 | $7.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $16.18M derived: sum of 2 quarters · filed 2022-11-08 | $25.43M 10-Q · filed 2022-11-08 | $32.22M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $8.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $18.19M 10-Q · filed 2022-08-04 | $24.99M derived: sum of 3 quarters · filed 2023-02-27 | $34.73M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $9.24M 10-Q · filed 2022-05-09 | $16.04M derived: sum of 2 quarters · filed 2023-02-27 | $25.78M derived: sum of 3 quarters · filed 2023-02-27 | $37.30M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $16.53M derived: sum of 2 quarters · filed 2023-02-27 | $28.06M derived: sum of 3 quarters · filed 2023-02-27 | $33.68M 10-K · filed 2023-02-27 |
| 2020-09-30 | $9.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $21.26M derived: sum of 2 quarters · filed 2021-10-28 | $26.89M 10-Q · filed 2021-10-28 | $30.76M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $11.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $17.15M 10-Q · filed 2021-07-29 | $21.02M derived: sum of 3 quarters · filed 2022-03-01 | $23.46M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $5.63M 10-Q · filed 2021-04-28 | $9.50M derived: sum of 2 quarters · filed 2022-03-01 | $11.94M derived: sum of 3 quarters · filed 2022-03-01 | $15.44M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.31M derived: sum of 2 quarters · filed 2022-03-01 | $9.81M derived: sum of 3 quarters · filed 2022-03-01 | $12.74M 10-K · filed 2022-03-01 |
| 2019-09-30 | $2.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $5.93M derived: sum of 2 quarters · filed 2020-10-29 | $8.87M 10-Q · filed 2020-10-29 | $11.90M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | $3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $6.43M 10-Q · filed 2020-07-31 | $9.47M derived: sum of 3 quarters · filed 2021-02-18 | $21.50M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | $2.93M 10-Q · filed 2020-05-06 | $5.97M derived: sum of 2 quarters · filed 2021-02-18 | $18.00M derived: sum of 3 quarters · filed 2021-02-18 | $24.82M derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | $3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $15.07M derived: sum of 2 quarters · filed 2021-02-18 | $21.89M derived: sum of 3 quarters · filed 2021-02-18 | $27.86M 10-K · filed 2021-02-18 |
| 2018-09-30 | $12.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $18.85M derived: sum of 2 quarters · filed 2019-11-05 | $24.82M 10-Q · filed 2019-11-05 | $39.29M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $6.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $12.79M 10-Q · filed 2019-08-07 | $27.25M derived: sum of 3 quarters · filed 2020-03-02 | $42.51M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $5.97M 10-Q · filed 2019-05-08 | $20.44M derived: sum of 2 quarters · filed 2020-03-02 | $35.69M derived: sum of 3 quarters · filed 2020-03-02 | $42.96M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $14.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $29.72M derived: sum of 2 quarters · filed 2020-03-02 | $36.99M derived: sum of 3 quarters · filed 2020-03-02 | $46.52M 10-K · filed 2020-03-02 |
| 2017-09-30 | $15.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $22.52M derived: sum of 2 quarters · filed 2018-11-09 | $32.06M 10-Q · filed 2018-11-09 | $33.59M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $7.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $16.80M 10-Q · filed 2018-08-07 | $18.34M derived: sum of 3 quarters · filed 2019-03-01 | $22.49M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $9.54M 10-Q · filed 2018-05-08 | $11.07M derived: sum of 2 quarters · filed 2019-03-01 | $15.22M derived: sum of 3 quarters · filed 2019-03-01 | $18.27M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $5.68M derived: sum of 2 quarters · filed 2019-03-01 | $8.73M derived: sum of 3 quarters · filed 2019-03-01 | $18.55M 10-K · filed 2019-03-01 |
| 2016-09-30 | $4.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $7.20M derived: sum of 2 quarters · filed 2017-11-08 | $17.02M 10-Q · filed 2017-11-08 | $23.44M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-06-30 | $3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $12.87M 10-Q · filed 2017-08-08 | $19.29M derived: sum of 3 quarters · filed 2019-01-29 | $22.27M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-03-31 | $9.81M 10-Q · filed 2017-05-10 | $16.24M derived: sum of 2 quarters · filed 2019-01-29 | $19.22M derived: sum of 3 quarters · filed 2019-01-29 | $20.30M derived: sum of 4 quarters · filed 2019-01-29 |
| 2015-12-31 | $6.42M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $9.41M derived: sum of 2 quarters · filed 2019-01-29 | $10.48M derived: sum of 3 quarters · filed 2019-01-29 | $10.85M 8-K · filed 2019-01-29 |
| 2015-09-30 | $2.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $4.06M derived: sum of 2 quarters · filed 2016-11-07 | $4.42M 10-Q · filed 2016-11-07 | $5.22M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $1.44M 10-Q · filed 2016-08-08 | $2.24M derived: sum of 3 quarters · filed 2017-03-01 | $3.71M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $363.00K 10-Q · filed 2016-05-09 | $1.16M derived: sum of 2 quarters · filed 2017-03-01 | $2.63M derived: sum of 3 quarters · filed 2017-03-01 | $4.24M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $799.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.27M derived: sum of 2 quarters · filed 2017-03-01 | $3.87M derived: sum of 3 quarters · filed 2017-03-01 | $4.73M 10-K · filed 2017-03-01 |
| 2014-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $3.07M derived: sum of 2 quarters · filed 2015-11-09 | $3.94M 10-Q · filed 2015-11-09 | $4.91M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $2.47M 10-Q · filed 2015-08-05 | $3.44M derived: sum of 3 quarters · filed 2016-02-29 | $4.38M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $861.00K 10-Q · filed 2015-05-11 | $1.83M derived: sum of 2 quarters · filed 2016-02-29 | $2.77M derived: sum of 3 quarters · filed 2016-02-29 | $4.07M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $971.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.91M derived: sum of 2 quarters · filed 2016-02-29 | $3.21M derived: sum of 3 quarters · filed 2016-02-29 | $3.96M 10-K · filed 2016-02-29 |
| 2013-09-30 | $937.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $2.24M derived: sum of 2 quarters · filed 2014-11-07 | $2.99M 10-Q · filed 2014-11-07 | $3.40M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $2.05M 10-Q · filed 2014-08-11 | $2.46M derived: sum of 3 quarters · filed 2015-02-27 | $3.12M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $755.00K 10-Q · filed 2014-05-09 | $1.16M derived: sum of 2 quarters · filed 2015-02-27 | $1.82M derived: sum of 3 quarters · filed 2015-02-27 | $2.05M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $408.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $1.06M derived: sum of 2 quarters · filed 2015-02-27 | $1.30M derived: sum of 3 quarters · filed 2015-02-27 | $1.47M 10-K · filed 2015-02-27 |
| 2012-09-30 | $656.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $889.00K derived: sum of 2 quarters · filed 2013-11-12 | $1.06M 10-Q · filed 2013-11-12 | $1.77M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $233.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $408.00K 10-Q · filed 2013-08-09 | $1.11M derived: sum of 3 quarters · filed 2014-03-03 | $1.82M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $175.00K 10-Q · filed 2013-05-10 | $879.00K derived: sum of 2 quarters · filed 2014-03-03 | $1.59M derived: sum of 3 quarters · filed 2014-03-03 | $2.02M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $704.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $1.41M derived: sum of 2 quarters · filed 2014-03-03 | $1.84M derived: sum of 3 quarters · filed 2014-03-03 | $1.95M 10-K · filed 2014-03-03 |
| 2011-09-30 | $707.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.14M derived: sum of 2 quarters · filed 2012-11-09 | $1.25M 10-Q · filed 2012-11-09 | $1.42M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $434.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $542.00K 10-Q · filed 2012-08-09 | $715.00K derived: sum of 3 quarters · filed 2013-03-18 | $806.00K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $108.00K 10-Q · filed 2012-05-10 | $281.00K derived: sum of 2 quarters · filed 2013-03-18 | $372.00K derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $173.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $264.00K derived: sum of 2 quarters · filed 2013-03-18 | $774.00K 10-K · filed 2013-03-18 | |
| 2010-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $601.00K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $510.00K 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $122.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |